Tag Archives: dose painting

Radiation Oncology Imaging Biomarkers
4
Feb

Overview

Imaging biomarkers quantify tumor characteristics to personalize radiotherapy. Functional imaging such as PET and MRI provides metrics for hypoxia perfusion and cellularity. Biomarkers support dose painting and adaptive strategies.

Imaging Modalities

PET tracers and MRI parametric maps offer complementary biomarker information. Multiparametric approaches improve characterization of tumor heterogeneity. Standardization is required for clinical implementation.

Clinical Trials

Biomarker driven trials evaluate imaging guided dose escalation and adaptive therapy. Imaging endpoints help assess early response and predict outcomes. Collaboration between imaging and radiation oncology is essential.

Implementation Challenges

Reproducibility and harmonization across scanners and sites are major hurdles. Regulatory and reimbursement frameworks influence adoption. Ongoing validation studies aim to demonstrate clinical benefit.

Radiation Oncology Imaging Journal
4
Feb

Overview

Radiation Oncology Imaging Journal focuses on imaging biomarkers for radiotherapy planning adaptive therapy and response assessment; it integrates PET MRI and CT based metrics for dose painting and toxicity prediction; multidisciplinary collaboration with radiation oncologists is central.

Planning and Simulation

Articles cover CT MRI and PET based simulation techniques and immobilization; image registration and motion management strategies are detailed; dosimetric implications of imaging findings are discussed.

Response Assessment

Imaging biomarkers for early response and normal tissue toxicity are evaluated; quantitative metrics and radiomic signatures are explored; adaptive workflows and trial designs are presented.

Clinical Trials and Standards

Prospective trials validating imaging guided radiotherapy are published; standardization of imaging protocols for multicenter trials is emphasized; regulatory and reimbursement considerations are addressed.